These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36300247)

  • 21. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
    Mertens LJ; Preller KH
    Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychedelics and hypnosis: Commonalities and therapeutic implications.
    Lemercier CE; Terhune DB
    J Psychopharmacol; 2018 Jul; 32(7):732-740. PubMed ID: 29938563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dangerous method? Psychedelic therapy at Modum Bad, Norway, 1961-76.
    Johnstad PG
    Hist Psychiatry; 2020 Jun; 31(2):217-226. PubMed ID: 31928087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.
    Gobbi G; Inserra A; Greenway KT; Lifshitz M; Kirmayer LJ
    Transcult Psychiatry; 2022 Oct; 59(5):718-724. PubMed ID: 36263521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An introduction to psychedelic neuroscience.
    Calvey T; Howells FM
    Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature.
    Golden TL; Magsamen S; Sandu CC; Lin S; Roebuck GM; Shi KM; Barrett FS
    Curr Top Behav Neurosci; 2022; 56():35-70. PubMed ID: 35138585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts.
    Graziosi M; Singh M; Nayak SM; Yaden DB
    J Psychoactive Drugs; 2023; 55(5):558-569. PubMed ID: 37679890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with psychedelics is psychotherapy: beyond reductionism.
    Gründer G; Brand M; Mertens LJ; Jungaberle H; Kärtner L; Scharf DJ; Spangemacher M; Wolff M
    Lancet Psychiatry; 2024 Mar; 11(3):231-236. PubMed ID: 38101439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychedelics and Evidence-based Psychotherapy: A Systematic Review with Recommendations for Advancing Psychedelic Therapy Research.
    Leone L; McSpadden B; DeMarco A; Enten L; Kline R; Fonzo GA
    Psychiatr Clin North Am; 2024 Jun; 47(2):367-398. PubMed ID: 38724126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychedelics action and schizophrenia.
    Maćkowiak M
    Pharmacol Rep; 2023 Dec; 75(6):1350-1361. PubMed ID: 37899392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Psychedelic Renaissance and Its Forensic Implications.
    Holoyda B
    J Am Acad Psychiatry Law; 2020 Mar; 48(1):87-97. PubMed ID: 31948993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychedelics and Psychotherapy.
    Nayak S; Johnson MW
    Pharmacopsychiatry; 2021 Jul; 54(4):167-175. PubMed ID: 33285578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.